newsfilter
← Latest News
GlobeNewswire·

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

  • Apyx Medical Corporation will have management participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA.
  • CEO Charlie Goodwin & CFO Matt Hill will join a fireside chat on August 11, 2026, at 2:30pm ET.
  • The fireside chat will be streamed via live webcast with a replay available on the company's Investor Relations website.
  • Management will conduct one-on-one investor meetings throughout the conference day.
  • Apyx Medical markets Renuvion® & the AYON Body Contouring System™ in the cosmetic surgery market & J-Plasma® in the hospital surgical market.
  • Renuvion & J-Plasma utilize Helium Plasma Platform Technology to provide controlled heat to tissue, supported by over 90 clinical documents.
  • The FDA-cleared AYON Body Contouring System combines fat removal, closed loop contouring, electrosurgical capabilities, & Renuvion for tissue contraction.
  • The company leverages expertise in unique waveforms through OEM agreements with other medical device manufacturers.
  • Investor inquiries can be directed to Jeremy Feffer of LifeSci Advisors at 212-915-2568 or jfeffer@lifesciadvisors.com.